Login / Signup
Stergios Kechagias
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 6
Top Topics
Molecularly Imprinted
Clinical Evaluation
Fluorescent Probe
Chronic Kidney Disease
Top Venues
Hepatology communications
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Julia Blomdahl
,
Patrik Nasr
,
Mattias Ekstedt
,
Stergios Kechagias
Moderate alcohol consumption is associated with significant fibrosis progression in NAFLD.
Hepatology communications
7 (1) (2023)
Lina Gruneau
,
Stergios Kechagias
,
Per Sandström
,
Mattias Ekstedt
,
Martin Henriksson
Cost-effectiveness analysis of noninvasive tests to identify advanced fibrosis in non-alcoholic fatty liver disease.
Hepatology communications
7 (7) (2023)
Julia Blomdahl
,
Patrik Nasr
,
Mattias Ekstedt
,
Stergios Kechagias
Moderate alcohol consumption is associated with significant fibrosis progression in NAFLD.
Hepatology communications
7 (1) (2023)
Julia Blomdahl
,
Patrik Nasr
,
Mattias Ekstedt
,
Stergios Kechagias
Moderate alcohol consumption is associated with significant fibrosis progression in NAFLD.
Hepatology communications
7 (1) (2023)
Julia Blomdahl
,
Patrik Nasr
,
Mattias Ekstedt
,
Stergios Kechagias
Moderate alcohol consumption is associated with significant fibrosis progression in NAFLD.
Hepatology communications
7 (1) (2023)
Julia Blomdahl
,
Patrik Nasr
,
Mattias Ekstedt
,
Stergios Kechagias
Moderate alcohol consumption is associated with significant fibrosis progression in NAFLD.
Hepatology communications
7 (1) (2023)